Latest Board Appointments News

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Altech Batteries has decided to discontinue its Silumina AnodesTM project after six years, shifting full focus to its CERENERGY® solid-state battery technology amid ongoing joint venture talks.

WA Kaolin is seeking up to A$34.9 million through a fully underwritten entitlement offer aimed at restructuring its balance sheet, reducing shareholder loans, and funding operational improvements at its Wickepin kaolin project.

Chatham Rock Phosphate has secured a definitive financing agreement with Wetstone Global that doubles an existing loan to USD 300,000 and converts it into a 30% equity stake, granting Wetstone majority board control and potential for up to 70% ownership upon project milestones.

Odessa Minerals has raised $2.65 million through a strongly supported placement and appointed Sam Brooks, an experienced geologist, to its board to boost project acquisition efforts.

MC Mining has secured a US$90 million capital injection from Kinetic Development Group, which now holds a 51% controlling stake, accelerating the Makhado Project towards production. New board appointments signal a strategic shift as the company pivots from development to operational ramp-up.

Cann Group’s CEO Jenni Pilcher steps down after leading a dramatic debt reduction and cost overhaul. Chairman Mike Ryan takes interim charge as the company hunts for a new CEO.

White Cliff Minerals has recommenced drilling at its Rae Copper Project, delivering high-grade copper-silver results and metallurgical testwork supporting simplified processing. The company agreed to sell its Great Bear Project for A$5.8 million, refocusing resources on Rae.

RareX Limited has advanced its rare earths ambitions by securing a key mining lease at Cummins Range, appointing a strategic board member, and raising $5 million to fund exploration and development.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

Terra Critical Minerals has established a US foothold with the True American Tungsten Project acquisition while progressing key Australian and Canadian critical metals projects, positioning for upcoming drilling campaigns.

Blackstone Minerals has cleared a key regulatory hurdle at its Mankayan Copper-Gold Project, lifting a Cease and Desist Order and initiating a Pre-Feasibility Study. The company also strengthened its board with mining veteran Mark Williams and reported a solid cash position of $14.6 million.